Use and production of storage-stable neutral metalloprotease
US-11091750-B2 · Aug 17, 2021 · US
US12043853B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12043853-B2 |
| Application number | US-202117376669-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 15, 2021 |
| Priority date | Oct 12, 2005 |
| Publication date | Jul 23, 2024 |
| Grant date | Jul 23, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides methods and compositions comprising at least one neutral metalloprotease enzyme that has improved storage stability. In some embodiments, the neutral metalloprotease finds use in cleaning and other applications. In some particularly preferred embodiments, the present invention provides methods and compositions comprising neutral metalloprotease(s) obtained from Bacillus sp. In some more particularly preferred embodiments, the neutral metalloprotease is obtained from B. amyloliquefaciens. In still further preferred embodiments, the neutral metalloprotease is a variant of the B. amyloliquefaciens neutral metalloprotease. In yet additional embodiments, the neutral metalloprotease is a homolog of the the B. amyloliquefaciens neutral metalloprotease. The present invention finds particular use in applications including, but not limited to cleaning, bleaching and disinfecting.
Opening claim text (preview).
What is claimed: 1. An isolated neutral metalloprotease variant having an amino acid sequence comprising at least one substitution of an amino acid made at a position equivalent to a position in a neutral metalloprotease comprising the amino acid sequence set forth in SEQ ID NO:18, wherein said protease comprises the substitution E152H, and wherein said variant has at least 90% amino acid sequence identity to SEQ ID NO: 18. 2. The isolated variant neutral metalloprotease of claim 1 , wherein said protease comprises multiple mutations selected from E152H/T179P, F130L/M138L/E152H/T179P, F130I/M138L/E152H/T179P, F130I/E152H/T179P, F30I/E152H/T179P, F130I/E152W/T179P, F130L/M138L/E152H, F130L/E152H, F130I/M138L/E152H, F130V/M138L/E152H, M138L/E152H, F130V/E152H/T179P, F130I/E52H, F130V/E152H. 3. The isolated variant neutral metalloprotease of claim 1 , wherein said protease comprises multiple mutations selected from S F130I/E152H, F130I/M138L/E152H/T179P, F130L/M138L/E152H/T179P, F130I/E152H/T179P, E152H/T179P, F130V/E152H/T179P, F130I/E152H, F130L/M138L/E152H, F130I/M138L/E152H, F130V/E152H, F130V/M138L/E152H, M138L/E152H. 4. The variant neutral metalloprotease of claim 1 , wherein the variant neutral metalloprotease has improved performance as compared to wild-type B. amyloliquefaciens neutral metalloprotease. 5. The variant neutral metalloprotease of claim 4 , wherein said improved performance comprises improved thermostability, as compared to wild-type B. amyloliquefaciens neutral metalloprotease. 6. The variant neutral metalloprotease of claim 4 , wherein said improved performance comprises improved performance under lower or higher pH conditions, as compared to wild-type B. amyloliquefaciens neutral metalloprotease. 7. The variant neutral metalloprotease of claim 4 , wherein said improved performance comprises improved autolytic stability, as compared to wild-type B. amyloliquefaciens neutral metalloprotease. 8. A composition comprising at least one neutral metalloprotease according to claim 1 obtained from B. amyloliquefaciens , wherein said composition further comprises at least one ion calcium or zinc ion. 9. A composition comprising at least one neutral metalloprotease according to claim 1 obtained from B. amyloliquefaciens , wherein said composition further comprises at least one stabilizer. 10. The composition of claim 9 , wherein said stabilizer is selected from the group consisting of borax, glycerol, zinc ions, calcium ions, and calcium formate. 11. The composition of claim 9 , wherein said stabilizer is at least one competitive inhibitor that stabilizes said at least one neutral metalloprotease in the presence of an anionic surfactant. 12. A cleaning composition comprising the isolated neutral metalloprotease of claim 1 . 13. The cleaning composition of claim 12 , wherein said cleaning composition is a detergent. 14. The cleaning composition of claim 12 , further comprising at least one additional enzymes or enzyme derivatives selected from proteases, amylases, lipases, mannanases, pectinases, cutinases, oxidoreductases, hemicellulases, and cellulases. 15. The cleaning composition of claim 12 , wherein said composition comprises from about 0.001 to about 0.5 weight percent of said neutral metalloprotease. 16. The cleaning composition of claim 12 , wherein said composition further comprises at least one adjunct ingredient. 17. The cleaning composition of claim 12 , wherein said composition is a liquid. 18. A method of cleaning, comprising the step of contacting a surface or an article comprising a fabric with the cleaning composition of claim 12 .
Metalloendopeptidases (3.4.24) · CPC title
Anionic compounds {(C11D1/002, C11D1/004, C11D1/008 take precedence)} · CPC title
Stabilised liquid enzyme compositions · CPC title
Preparations containing enzymes {, e.g. protease or amylase} · CPC title
with enzymes or microorganisms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.